Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;18(2):210163.
doi: 10.1183/20734735.0163-2021. Epub 2022 Aug 9.

Non-traumatic chylothorax: diagnostic and therapeutic strategies

Affiliations
Review

Non-traumatic chylothorax: diagnostic and therapeutic strategies

Khalil Ur Rehman et al. Breathe (Sheff). 2022 Jun.

Abstract

Non-traumatic chylothorax refers to accumulation of chyle in the pleural space in the absence of any traumatic disruption to the thoracic duct. Chyle originates from the intestines and is transported via the thoracic duct into systemic circulation. The anatomical course of the thoracic duct is complex with considerable variation; therefore, development of chylothorax is dependent on the site and level of the thoracic duct defect. Non-traumatic chylothorax is associated with a wide range of medical disorders, but malignancy accounts for three-quarters of cases. In up to 9% of cases, the aetiology remains unknown (termed idiopathic chylothorax). Gross appearance of pleural fluid is neither sensitive nor specific enough to diagnose chylothorax; therefore, biochemical analysis of the pleural fluid is required. Pleural fluid triglyceride level >1.24 mmol·L-1 (110 mg·dL-1) with a cholesterol level <5.18 mmol·L-1 (200 mg·dL-1) is diagnostic of chylothorax. In borderline cases, lipoprotein electrophoresis can help confirm the diagnosis by detecting chylomicrons in the pleural fluid. Once the diagnosis of chylothorax is confirmed, the next step is to find the cause and identify the leakage point, for which various lymphatic specific radiological investigations may have an important role. There is paucity of data on the most suitable approach to manage non-traumatic chylothoraces and treatment often depends on the underlying cause. In general, conservative treatment is tried first, usually for a limited time, before considering more invasive measures. A multidisciplinary approach is recommended with close liaison among the respiratory physicians, thoracic surgeons, oncologists, interventional radiologists, dietitians and pharmacists.

Educational aims: To review the pathophysiology, aetiology, and epidemiology of non-traumatic chylothorax.To discuss diagnostic and therapeutic strategies in the management of non-traumatic chylothorax.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: K. Ur Rehman has nothing to disclose. Conflict of interests: P. Sivakumar has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Diffusion of triglycerides into lacteals. Fatty acids and glycerol molecules diffuse into the intestinal cells. Once in the cell, fatty acids and glycerol molecules can recombine into triglycerides and then diffuse into the lacteal. Adapted from “Absorption of Nutrients in the Small Intestine”, by BioRender.com (2021). Retrieved from https://app.biorender.com/biorender-templates.
FIGURE 2
FIGURE 2
Anatomical course of the thoracic duct.
FIGURE 3
FIGURE 3
Diagnostic algorithm of chylothorax.
FIGURE 4
FIGURE 4
Milky appearance of pleural fluid in a patient with chylothorax.
FIGURE 5
FIGURE 5
Proposed treatment algorithm for non-traumatic chylothorax. MDT: multidisciplinary team. #: CT/MR lymphangiography, SPECT/CT or lymphoscintigraphy, etc., as appropriate; : these can also be used in conjunction whilst treating the underlying cause or awaiting imaging work-up or definitive treatment.

References

    1. Maldonado F, Cartin-Ceba R, Hawkins FJ, et al. . Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339: 314–318. doi:10.1097/MAJ.0b013e3181cdcd6c - DOI - PubMed
    1. Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 2010; 31: 743–750. doi:10.1055/s-0030-1269834 - DOI - PubMed
    1. Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007; 32: 362–369. doi:10.1016/j.ejcts.2007.04.024 - DOI - PubMed
    1. McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010; 104: 1–8. doi:10.1016/j.rmed.2009.08.010 - DOI - PubMed
    1. Bessone LN, Ferguson TB, Burford TH. Chylothorax. Ann Thorac Surg 1971; 12: 527–550. doi:10.1016/S0003-4975(10)65800-6 - DOI - PubMed

LinkOut - more resources